On AMDL ELISA DR-70 Blood Test for Colorectal Cancer Surveillance MarketAMDL http://silagrapro.com.

On AMDL – ELISA DR-70 Blood Test for Colorectal Cancer Surveillance MarketAMDL, a leading vertically integrated bio-pharmaceutical company with operations in China and the U.S http://silagrapro.com ., today announced the U.S. – Food and Drug Administration has issued a letter of substantial equivalence to an existing predicate device and granted clearance to the AMDL – ELISA DR-7 as a safe and effective blood test for monitoring patients with previously the diagnose colorectal cancer market.

About AMDL – ELISA DR-70 DR-70 is an Enzyme-Linked is immunosorbent assay – a sensitive, well – established diagnostic laboratory test, easily and cost can be added to the existing line of diagnostics routinely performed by clinical laboratories in the United States by more information about the AMDL – ELISA DR-70 test to AMDL corporate website at at or contact the company at 714.4460.

read more

We took that lawn Nobody having taken this week a child and family We are purpose. Our attention on the new dialogue on health care reform in of that generation and the rightful place for all skilled primary health care services vendors of children’s healthcare and make our vital work to promote health of children, said NAPNAP Chief Executive Officer Karen Kelly Thomas.

click to see more